Sunitinib Malate(CAS: 341031-54-7)

Sunitinib Malate (CAS: 341031-54-7) is a multi-targeted tyrosine kinase inhibitor used in cancer therapy. Its chemical formula is C27H31N7O10S·C4H6O4, and it is a white to off-white solid with good solubility in water. It is commonly used in pharmaceutical applications for its anti-cancer properties and is known for its ability to inhibit multiple receptor tyrosine kinases involved in tumor growth.

Sunitinib Malate (CAS: 341031-54-7) is primarily used in oncology to treat various types of cancer, including gastrointestinal stromal tumors (GIST), renal cell carcinoma, and pancreatic neuroendocrine tumors. It is also used in research for studying kinase inhibition and in pharmaceutical development for drug formulation and clinical trials. As a synthetic compound, it has applications in drug discovery and targeted therapy.

Sunitinib Malate (CAS: 341031-54-7) is generally considered safe when used as prescribed in medical settings. However, it may cause side effects such as fatigue, nausea, and hypertension. Proper handling and use under medical supervision are essential to ensure safety. It is important to follow safety guidelines and protective measures to minimize risks during storage, transportation, and administration.

Sunitinib Malate (CAS: 341031-54-7) should be stored in a cool, dry, and dark place, ideally at 20-25°C. It should be kept in a sealed container away from moisture and light to maintain its stability and potency. Proper storage conditions are crucial to ensure the compound remains effective and safe for use in pharmaceutical and research applications.